Holen Sie sich die Stockscreener-App
9.66
1.52%
0.145
Handel nachbörslich:
9.66
Schlusskurs vom Vortag:
$9.515
Offen:
$9.52
24-Stunden-Volumen:
92,073
Relative Volume:
1.09
Marktkapitalisierung:
$59.44M
Einnahmen:
$7.97M
Nettoeinkommen (Verlust:
$-75.74M
KGV:
-0.3978
EPS:
-24.2853
Netto-Cashflow:
$-85.33M
1W Leistung:
+21.97%
1M Leistung:
-0.26%
6M Leistung:
+75.64%
1J Leistung:
-52.79%
1-Tages-Spanne:
$9.385
$9.98
1-Wochen-Bereich:
$8.00
$9.98
52-Wochen-Spanne:
$3.76
$46.80
Aligos Therapeutics Inc Stock (ALGS) Company Profile
Firmenname
Aligos Therapeutics Inc
Sektor
Branche
Telefon
(800) 466-6059
Adresse
ONE CORPORATE DR., 2ND FLOOR, SOUTH SAN FRANCISCO
Vergleichen Sie ALGS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ALGS
Aligos Therapeutics Inc
|
9.66 | 58.55M | 7.97M | -75.74M | -85.33M | -24.29 |
|
VRTX
Vertex Pharmaceuticals Inc
|
429.82 | 107.58B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
787.32 | 80.03B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
429.80 | 57.37B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
917.93 | 55.83B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
209.02 | 44.13B | 447.02M | -1.18B | -906.14M | -6.1812 |
Aligos Therapeutics Inc Stock (ALGS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-18 | Fortgesetzt | H.C. Wainwright | Buy |
| 2024-08-19 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-01-06 | Hochstufung | Jefferies | Hold → Buy |
| 2023-01-06 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2022-03-23 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-01-07 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-01-06 | Herabstufung | Jefferies | Buy → Hold |
| 2021-09-09 | Eingeleitet | SVB Leerink | Outperform |
| 2021-05-17 | Fortgesetzt | Piper Sandler | Overweight |
| 2020-11-10 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-11-10 | Eingeleitet | JP Morgan | Overweight |
| 2020-11-10 | Eingeleitet | Jefferies | Buy |
| 2020-11-10 | Eingeleitet | Piper Sandler | Overweight |
Alle ansehen
Aligos Therapeutics Inc Aktie (ALGS) Neueste Nachrichten
Aligos Therapeutics Stock Rockets 57% With 7-Day Winning Streak - Trefis
Understanding the Setup: (ALGS) and Scalable Risk - news.stocktradersdaily.com
Is Aligos Therapeutics Inc. (5WK0) stock a good hedge against inflationJuly 2025 Sector Moves & Breakout Confirmation Alerts - newser.com
Why Aligos Therapeutics Inc. stock could outperform in 2025Market Growth Summary & AI Optimized Trade Strategies - newser.com
Transcript : Aligos Therapeutics, Inc. Presents at Jefferies London Healthcare Conference 2025, Nov-17-2025 03 - MarketScreener
Is Aligos Therapeutics Inc. stock undervalued vs historical averagesEntry Point & Entry Point Confirmation Alerts - newser.com
What moving averages say about Aligos Therapeutics Inc.2025 Key Highlights & Risk Controlled Stock Alerts - newser.com
How supply shortages influence Aligos Therapeutics Inc. (5WK0) stockTreasury Yields & Weekly Chart Analysis and Trade Guides - newser.com
Can Aligos Therapeutics Inc. (5WK0) stock sustain margin levels2025 Geopolitical Influence & Safe Investment Capital Preservation Plans - newser.com
Will Aligos Therapeutics Inc. (5WK0) stock outperform global peersJuly 2025 Analyst Calls & Short-Term High Return Ideas - newser.com
When is the best time to exit Aligos Therapeutics Inc.July 2025 Earnings & High Win Rate Trade Alerts - newser.com
Is Aligos Therapeutics Inc. (5WK0) stock a buy on weaknessOptions Play & Community Driven Trade Alerts - newser.com
What makes Aligos Therapeutics Inc. (5WK0) stock appealing to growth investorsMarket Performance Recap & Technical Confirmation Trade Alerts - newser.com
How buybacks impact Aligos Therapeutics Inc. stock valueBull Run & Accurate Trade Setup Notifications - newser.com
What is the fair value estimate for Aligos Therapeutics Inc. (5WK0) stock in 2025Chart Signals & AI Enhanced Market Trend Forecasts - newser.com
Will Aligos Therapeutics Inc. benefit from macro trendsJuly 2025 Closing Moves & Verified Momentum Stock Ideas - newser.com
Can Aligos Therapeutics Inc. (5WK0) stock sustain institutional flowsQuarterly Portfolio Report & Smart Investment Allocation Insights - newser.com
Why Aligos Therapeutics Inc. stock remains on buy listsGlobal Markets & Community Trade Idea Sharing Platform - newser.com
Is Aligos Therapeutics Inc. (5WK0) stock resilient in recession scenariosWeekly Stock Summary & Long-Term Growth Stock Strategies - newser.com
Finanzdaten der Aligos Therapeutics Inc-Aktie (ALGS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.53%
1.88%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):